Newsmeme!
Discover News you didn't know existed
Epithelium
News
Helsinn Healthcare signs partnering pact with Zealand Pharma for ZP1846
Published November 28, 2008, 9:51 pm, PharmaBiz
Helsinn Healthcare's Top management announced that it has signed a partnering agreement with Zealand Pharma, for the development and worldwide commercialization of ZP1846, a GLP-2 (glucagon-like peptide-2) receptor agonist which provides a novel way to treat chemotherapy-induced diarrhoea (CID), a debilitating condition affecting patients undergoing cancer treatment with a range of chemotherapies.
cancer treatment chemotherapy diarrhoea glucagon
helsinn healthcare pact peptide receptor agonist
signs top management worldwide commercialization zealand pharma
helsinn healthcare pact peptide receptor agonist
signs top management worldwide commercialization zealand pharma
Tags
No tags found at this time. Be the first to tag this news item, learn more.
Imagery
Related Epithelium Stories
From Various News Sources
No related news stories found.
Related Social Bookmarks
None found at this time.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |